Evidence-based nursing practice for low-molecular-weight heparin subcutaneous injection in inpatients based on evidence-based continuous quality improvement model
10.3760/cma.j.cn115682-20191104-04001
- VernacularTitle:基于证据的持续质量改进模式的住院患者低分子肝素皮下注射的循证护理实践
- Author:
Xiaohong LU
1
;
Shaoling LI
;
Yan CUI
;
Lili WEI
;
Qian ZHAO
;
Shaoshao WANG
;
Yu CHEN
Author Information
1. 青岛大学附属医院心血管内科，青岛 266000
- Keywords:
Injections, subcutaneous;
Low molecular weight hepari;
Evidence-based nursing practice;
Quality improvement
- From:
Chinese Journal of Modern Nursing
2020;26(28):3940-3945
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To establish an evidence-based nursing practice standard for subcutaneous injection of low-molecular-weight heparin in inpatients so as to improve the evidence awareness of nurses and the standard rate of clinical practice and reduce the incidence of adverse reactions in patients.Methods:From June 2018 to June 2019, we analyzed the obstacle to evidence application and formulated available solutions according to the standard procedure of evidence-based continuous quality improvement and by combining promotion framework (i-PARIHS) . We selected 44 nurses and 80 patients of Department of Cardiovascular Medicine at a general Class Ⅲ Grade A hospital in Qingdao as the research object to carry out quality review and effect evaluation before evidence application, in the first round and the second round after evidence application.Results:In the second round of review after evidence application, the awareness and implementation rate were significantly improved, and the incidence of ecchymosis, induration, bleeding and the VAS score were significantly reduced with statistical differences ( P<0.05) . The department related work process was improved, and the evidence-based nursing practice standard for subcutaneous injection of low-molecular-weight heparin in inpatients was formed. Conclusions:The clinical development of the evidence-based project can standardize nurses' operation behavior of subcutaneous injection of low molecular weight heparin and reduce the incidence of adverse reactions in patients.
